Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia

Item

http://www.wikidata.org/entity/Q35562821

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@ast

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@en

type

Item

label

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@ast

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@en

prefLabel

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@ast

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@en

P1476

Integrated genomic profiling, ...... ult acute myelogenous leukemia

@en

P2093

Kamlai Saiya-Cork

http://www.w3.org/2001/XMLSchema#string

Mehmet Yildiz

http://www.w3.org/2001/XMLSchema#string

Peter Ouillette

http://www.w3.org/2001/XMLSchema#string

Sami N Malek

http://www.w3.org/2001/XMLSchema#string

P2860

DNMT3A Mutations in Acute Myeloid Leukemia

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Implications of NRAS mutations in AML: a study of 2502 patients.

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

P304

2045-2056

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-0921

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kerby Shedden

Brian Parkin

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25652455

http://www.w3.org/2001/XMLSchema#string

P932

4417381

http://www.w3.org/2001/XMLSchema#string